Does LEVOMILNACIPRAN Cause Exostosis? 55 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Exostosis have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 4.0% of all adverse event reports for LEVOMILNACIPRAN.
55
Reports of Exostosis with LEVOMILNACIPRAN
4.0%
of all LEVOMILNACIPRAN reports
55
Deaths
55
Hospitalizations
How Dangerous Is Exostosis From LEVOMILNACIPRAN?
Of the 55 reports, 55 (100.0%) resulted in death, 55 (100.0%) required hospitalization, and 55 (100.0%) were considered life-threatening.
Is Exostosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Exostosis?
ADALIMUMAB (2,008)
METHOTREXATE (968)
ETANERCEPT (918)
ABATACEPT (775)
TOCILIZUMAB (768)
LEFLUNOMIDE (743)
SULFASALAZINE (712)
DICLOFENAC (702)
TOFACITINIB (702)
CERTOLIZUMAB PEGOL (695)
Which LEVOMILNACIPRAN Alternatives Have Lower Exostosis Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE